Functional characterization of a putative tumor necrosis factor superfamily member 10 in blood clam (Tegillarca granosa)

The stress–immunity axis in shellfish

(2020) Christopher J. Coates et al.   JOURNAL OF INVERTEBRATE PATHOLOGY

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells

(2019) Anna Willms et al.   PLoS One

Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5

(2019) Carles Solà-Riera et al.   Cell Reports

Functional characterization of a putative lipopolysaccharide-induced TNF-alpha factor (LITAF) from blood clam Tegillarca granosa in innate immunity

(2019) Guosheng Liu et al.   FISH & SHELLFISH IMMUNOLOGY

SWISS-MODEL: homology modelling of protein structures and complexes

(2018) Andrew Waterhouse et al.   NUCLEIC ACIDS RESEARCH

Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy

(2018) Fei Yi et al.   TRENDS IN MOLECULAR MEDICINE

Molecular cloning, characterization and functional analysis of a putative mitogen-activated protein kinase kinase kinase 4 (MEKK4) from blood clam Tegillarca granosa

(2017) Guosheng Liu et al.   FISH & SHELLFISH IMMUNOLOGY

Benzo[a]pyrene exposure under future ocean acidification scenarios weakens the immune responses of blood clam, Tegillarca granosa

(2017) Wenhao Su et al.   FISH & SHELLFISH IMMUNOLOGY

Ocean acidification weakens the immune response of blood clam through hampering the NF-kappa β and toll-like receptor pathways

(2016) Saixi Liu et al.   FISH & SHELLFISH IMMUNOLOGY

Characteristics of chitin synthase (CHS) gene and its function in polyspermy blocking in the blood clamTegillarca granosa

(2016) Yu Han et al.   JOURNAL OF MOLLUSCAN STUDIES

MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets

(2016) Sudhir Kumar et al.   MOLECULAR BIOLOGY AND EVOLUTION

TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors

(2016) Verena Zoller et al.   Cell Death & Disease

IBS: an illustrator for the presentation and visualization of biological sequences: Fig. 1.

(2015) Wenzhong Liu et al.   BIOINFORMATICS

Immunoglobulin Fc Domain Fusion to TRAIL Significantly Prolongs Its Plasma Half-Life and Enhances Its Antitumor Activity

(2014) H. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors

(2013) Sunil Sharma et al.   INVESTIGATIONAL NEW DRUGS

Immune toxicity of TiO2 under hypoxia in the green-lipped mussel Perna viridis based on flow cytometric analysis of hemocyte parameters

(2013) Youji Wang et al.   SCIENCE OF THE TOTAL ENVIRONMENT

New and continuing developments at PROSITE

(2012) Christian J. A. Sigrist et al.   NUCLEIC ACIDS RESEARCH

Expression of TRAIL in liver tissue from patients with different outcomes of HBV infection

(2012) Fan-wei Liu et al.   Clinics and Research in Hepatology and Gastroenterology

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

(2010) D. R. Camidge et al.   CLINICAL CANCER RESEARCH

Identification and functional characterization of a human sTRAIL homolog, CasTRAIL, in an invertebrate oyster Crassostrea ariakensis

(2010) Shoubao Yang et al.   DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY

Role for a somatically diversified lectin in resistance of an invertebrate to parasite infection

(2010) P. C. Hanington et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

(2009) H. A. Wakelee et al.   ANNALS OF ONCOLOGY

To kill a tumor cell: the potential of proapoptotic receptor agonists

(2008) Avi Ashkenazi et al.   JOURNAL OF CLINICAL INVESTIGATION

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

(2008) Avi Ashkenazi   NATURE REVIEWS DRUG DISCOVERY